Pfizer Revs Acquisition Engine; New Management Has $17 Bil. To Spend On Deals
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer signs licensing agreement with Quark Biotech to develop a novel human gene for treatment of wet age-related macular degeneration.
You may also be interested in...
Pfizer Plans R&D, Manufacturing Expansion In Asia
In another indication of big pharma's expanding interest in Asia, Pfizer announced Nov. 30 that it will seek to increase the amount of R&D and manufacturing it does in that part of the world
Pfizer Plans R&D, Manufacturing Expansion In Asia
Firm could double manufacturing outsourcing from its current 15 percent to 30 percent, with a focus on Asia.
Pfizer Plans R&D, Manufacturing Expansion In Asia
Firm could double manufacturing outsourcing from its current 15 percent to 30 percent, with a focus on Asia.